CD38 has emerged as a promising therapeutic target for cardio-protection as it has been implicated in the pathogenesis of several cardiovascular diseases including ischemia-reperfusion injury, atherosclerosis, cardiac arrhythmias, myocardial hypertrophy and pulmonary hypertension [53]. The gene discussed is CD38; the disease is pulmonary hypertension.